Bodrell Group is a consolidation of several companies with over 25years experience in their various fields. Created in 2005 in the principality of Andorra located in Europe Bodrell Group later moved its headquarters to Western Australia in 2007.

In the early 70's one of our founders the late Alan Bodger, performed the first environmental audit on a company within Australia, ALCOA, and continued to provide such consulting services in the environmental and sustainability fields to both private and government groups around the world including more recently the Prince's Rainforest Trust in the United Kingdom

During the early 80's Consolidated Communications led the industry with such technologies as True Sine Wave UPS systems supplied to several leading financial institutions. Consolidated Communications also consulted the US Government on various Communications projects for the Pentagon and associated agencies. Consolidated Communications also provided technical and engineering consultation to various commercial and government bodies around the world including Asia and Australia.

In the 90's our divisiion were successful designers of a variety of high end communication installations including consultation to the Department of Justice for Video Conference installations drawing on our vast knowledge and technical experience in the field. IT was also during this period we started development work in lighting solutions paying close attention to the evolving solid state lighting products such as Light Emitting Diodes.

With the new millenium came a new face for the group in EnviroLumiere. Our division specialising in low emission lighting technologies. We also started research into various BioTech products and Pharmaceuticals. EnviroLumiere was one of the first companies in the world to release a Solid State Lighting alternative to the traditional 50watt Halogen released in 2007/2008 and continues to develop leading solutions in this field. Our BioTech division is currently in the final stages of commercialising its current research project. Our Pharmaceuticals division continues its research into reducing the costs of mass produced pharmaceuticals for the benefit of mankind.